Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5JE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,276
Award facts
- Contract value 100% obligated
- $38,275.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,275.62 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pens on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract represents a non-competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, making this delivery order part of the Defense Logistics Agency's broader pharmaceutical supply chain supporting military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC enables Cencora and its subsidiary AmerisourceBergen Drug Corp to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military treatment facilities and federal healthcare programs globally. The contract structure allows the Defense Logistics Agency to issue task orders for specific medications and medical commodities as needed, with this particular order for Dupixent supporting military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FT5JE?
SPE2DR26FT5JE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FT5JE worth?
The government has obligated $38,276 on SPE2DR26FT5JE.
Is contract SPE2DR26FT5JE an order under another contract?
Yes. SPE2DR26FT5JE is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5JE competed?
The extent of competition for SPE2DR26FT5JE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award